...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: New paper on interplay/synergy of BET inhibitors and PD-L1 inhibition
Reply New Message
Back To Forum List View
Icon president New paper on interplay/synergy of BET inhibitors and PD-L1 inhibition
3
BearDownAZ
Mar 02, 2017 10:51AM
Re: New paper on interplay/synergy of BET inhibitors and PD-L1 inhibition
6
coldnewfie
Mar 02, 2017 06:54PM
Icon president Re: New paper on interplay/synergy of BET inhibitors and PD-L1 inhibition
4
SanFrancisco99
Mar 02, 2017 10:43PM
Re: New paper on interplay/synergy of BET inhibitors and PD-L1 inhibition
4
Nextblockbuster
Mar 03, 2017 10:01AM
Icon president Re: New paper on interplay/synergy of BET inhibitors and PD-L1 inhibition
3
SanFrancisco99
Mar 03, 2017 10:14AM
Icon president Re: New paper on interplay/synergy of BET inhibitors and PD-L1 inhibition
3
BearDownAZ
Mar 03, 2017 10:20AM
Re: New paper on interplay/synergy of BET inhibitors and PD-L1 inhibition
2
Nextblockbuster
Mar 03, 2017 11:04AM
Icon president Re: New paper on interplay/synergy of BET inhibitors and PD-L1 inhibition
5
BearDownAZ
Mar 03, 2017 01:10PM

Thank you Bear for you explanation, 

Can we however say that to this point  Zen3694 does not have any safety issues to warrant a stoppage of the trial, , which is a postive,     

3 Recommendations
Icon president Re: New paper on interplay/synergy of BET inhibitors and PD-L1 inhibition
3
BearDownAZ
Mar 03, 2017 02:07PM
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply